NASDAQ:ITRI - Itron Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $107.13
  • Forecasted Upside: 12.23 %
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$95.45
▲ +0.22 (0.23%)

This chart shows the closing price for ITRI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Itron Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ITRI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ITRI

Analyst Price Target is $107.13
▲ +12.23% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Itron in the last 3 months. The average price target is $107.13, with a high forecast of $140.00 and a low forecast of $56.00. The average price target represents a 12.23% upside from the last price of $95.45.

This chart shows the closing price for ITRI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 investment analysts is to buy stock in Itron. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/2/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/26/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/21/2021JPMorgan Chase & Co.Boost Price TargetAverage ➝ Overweight$110.00 ➝ $120.00High
6/18/2021Piper SandlerLower Price TargetOverweight$120.00 ➝ $110.00High
5/4/2021OppenheimerLower Price TargetOutperform$127.00 ➝ $105.00Low
5/4/2021Canaccord GenuityLower Price TargetBuy$140.00 ➝ $126.00High
3/31/2021Morgan StanleyInitiated CoverageEqual Weight$90.00Medium
3/26/2021JPMorgan Chase & Co.Initiated CoverageOverweight$110.00High
3/26/2021Piper SandlerInitiated CoverageOverweight$120.00High
3/3/2021ArgusUpgradeHold ➝ Buy$140.00Low
2/25/2021OppenheimerBoost Price TargetPositive ➝ Outperform$75.00 ➝ $127.00Low
1/8/2021Raymond JamesDowngradeStrong-Buy ➝ Outperform$78.00 ➝ $110.00High
10/15/2020StephensInitiated CoverageOverweightMedium
9/28/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$78.00High
8/25/2020Wolfe ResearchInitiated CoverageUnderperform$56.00Medium
8/11/2020OppenheimerInitiated CoverageBuy$75.00Low
8/4/2020OppenheimerLower Price TargetOutperform$82.00 ➝ $75.00High
8/4/2020Raymond JamesLower Price TargetOutperform$82.00 ➝ $78.00High
6/26/2020OppenheimerLower Price TargetOutperform$90.00 ➝ $82.00High
6/18/2020Canaccord GenuityReiterated RatingBuyLow
5/26/2020Johnson RiceInitiated CoverageBuy$80.00High
5/15/2020OppenheimerReiterated RatingBuy$90.00Low
5/5/2020JMP SecuritiesLower Price TargetMarket Outperform$95.00 ➝ $80.00High
5/5/2020CowenLower Price TargetOutperform$88.50 ➝ $78.00High
5/5/2020Canaccord GenuityReiterated RatingBuy$81.00High
5/5/2020OppenheimerReiterated RatingBuy$90.00High
3/19/2020ArgusDowngradeBuy ➝ HoldHigh
2/26/2020StephensLower Price TargetEqual Weight$96.00 ➝ $83.00High
2/25/2020JMP SecuritiesReiterated RatingOutperform$95.00High
11/5/2019OppenheimerBoost Price Target$75.00 ➝ $90.00Low
11/5/2019Robert W. BairdBoost Price TargetOutperform$80.00 ➝ $86.00High
10/21/2019Canaccord GenuityBoost Price TargetBuy$77.00 ➝ $87.00High
10/18/2019StephensSet Price TargetHold$83.00Low
10/1/2019Raymond JamesBoost Price TargetOutperform$75.00 ➝ $82.00High
9/18/2019Robert W. BairdReiterated RatingOutperform$70.00 ➝ $80.00High
8/20/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$75.00High
8/20/2019Credit Suisse GroupDowngradeOutperformHigh
8/16/2019ArgusUpgradeHold ➝ BuyMedium
7/8/2019StephensInitiated CoverageEqual ➝ Equal Weight$64.00Low
7/1/2019CitigroupBoost Price TargetOutperform$68.00 ➝ $75.00High
5/7/2019OppenheimerBoost Price TargetOutperform$60.00 ➝ $68.00High
5/7/2019Robert W. BairdUpgradeNeutral ➝ Outperform$56.00 ➝ $62.00High
2/28/2019CowenSet Price TargetBuy$67.00High
2/28/2019JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$80.00 ➝ $72.00High
2/28/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$70.00High
1/23/2019Needham & Company LLCLower Price TargetBuy$75.00Low
12/3/2018GuggenheimInitiated CoverageBuy ➝ Buy$70.00High
11/9/2018CowenReiterated RatingBuy$80.00High
11/8/2018ArgusDowngradeBuy ➝ HoldMedium
11/6/2018JMP SecuritiesSet Price TargetBuy$80.00High
8/22/2018ArgusUpgradeHold ➝ Buy$72.00Low
8/7/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$75.00 ➝ $68.00High
8/7/2018OppenheimerLower Price TargetOutperform ➝ Outperform$76.00 ➝ $72.00High
8/6/2018GuggenheimSet Price TargetBuy$73.00Low
8/6/2018CowenSet Price TargetBuy$80.00High
6/6/2018Canaccord GenuitySet Price TargetBuy$84.00Low
5/16/2018Canaccord GenuityReiterated RatingBuy$84.00Medium
4/4/2018Canaccord GenuityReiterated RatingBuy$84.00Low
3/22/2018MacquarieInitiated CoverageNeutral ➝ NeutralMedium
3/1/2018JMP SecuritiesSet Price TargetMarket Outperform ➝ Buy$108.00Low
3/1/2018CowenUpgradeMarket Perform ➝ Outperform$80.00 ➝ $84.00Medium
2/27/2018Canaccord GenuityUpgradeHold ➝ Buy$78.00 ➝ $84.00Medium
1/29/2018OppenheimerReiterated RatingBuy$78.00Low
1/2/2018Raymond JamesInitiated CoverageStrong-Buy ➝ Strong-Buy$84.00Medium
1/2/2018UBS GroupInitiated CoverageStrong-Buy$84.00Medium
12/27/2017Canaccord GenuityReiterated RatingHold$78.00Low
11/29/2017ArgusDowngradeBuy ➝ HoldMedium
11/3/2017Needham & Company LLCReiterated RatingBuy$84.00N/A
10/12/2017JMP SecuritiesSet Price TargetOutperform ➝ Buy$88.00 ➝ $102.00N/A
10/6/2017Canaccord GenuityReiterated RatingHold$78.00N/A
9/19/2017Canaccord GenuityDowngradeBuy ➝ Hold$78.00Low
9/12/2017Robert W. BairdReiterated RatingHold$77.00Low
9/12/2017ArgusReiterated RatingBuy$78.00 ➝ $80.00Low
8/4/2017OppenheimerReiterated RatingOutperform$75.00 ➝ $78.00Low
8/3/2017Needham & Company LLCReiterated RatingBuy$74.00 ➝ $84.00Low
8/3/2017CowenSet Price TargetHold$60.00 ➝ $74.00High
7/26/2017Robert W. BairdDowngradeOutperform ➝ Neutral$73.00 ➝ $77.00Low
7/21/2017CowenSet Price TargetHold$60.00Low
7/18/2017JMP SecuritiesSet Price TargetBuy$75.00 ➝ $88.00Medium
7/14/2017Canaccord GenuityReiterated RatingBuy$78.00Low
7/13/2017Robert W. BairdReiterated RatingOutperform$73.00Low
6/20/2017GuggenheimInitiated CoverageBuy ➝ Buy$81.00Low
5/26/2017Canaccord GenuityReiterated RatingBuy$72.00Low
3/9/2017JMP SecuritiesInitiated CoverageMkt Outperform ➝ Outperform$75.00Low
3/2/2017Robert W. BairdSet Price TargetBuy$73.00N/A
3/1/2017OppenheimerSet Price TargetBuy$70.00N/A
3/1/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$70.00 ➝ $74.00N/A
12/9/2016Robert W. BairdBoost Price TargetBuy$73.00N/A
12/6/2016Needham & Company LLCReiterated RatingBuy$66.00 ➝ $70.00N/A
12/5/2016OppenheimerSet Price TargetBuy$60.00 ➝ $70.00N/A
12/5/2016Robert W. BairdReiterated RatingOutperform$62.00N/A
11/19/2016Robert W. BairdReiterated RatingOutperform$62.00N/A
11/14/2016Needham & Company LLCBoost Price TargetBuy$60.00 ➝ $66.00N/A
11/4/2016Robert W. BairdReiterated RatingOutperform$62.00N/A
11/3/2016OppenheimerUpgradeMarket Perform ➝ Outperform$60.00N/A
11/3/2016UBS GroupUpgradeMarket Perform ➝ OutperformN/A
10/26/2016Robert W. BairdReiterated RatingOutperform$56.00 ➝ $62.00N/A
10/3/2016Canaccord GenuityReiterated RatingBuy$57.00 ➝ $61.00N/A
9/4/2016Robert W. BairdSet Price TargetBuy$56.00N/A
9/4/2016CowenReiterated RatingMarket Perform$45.00 ➝ $50.00N/A
9/2/2016Needham & Company LLCBoost Price TargetBuy$46.00 ➝ $60.00N/A
9/2/2016Canaccord GenuityReiterated RatingBuy$50.00 ➝ $57.00N/A
8/13/2016Robert W. BairdReiterated RatingOutperform$47.00N/A
(Data available from 7/26/2016 forward)
Itron logo
Itron, Inc. is a technology and services company, which engages in the provision of solutions that measure, manage, and analyze energy and water use. It operates through the following segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with its broader Itron systems. The Networked Solutions segment offers a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. The Outcomes segment consist of the firm's value-added, enhanced software and services operating segment in which it manage, organize, analyze, and interpret data to improve decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. The company was founded in 1977 and is headquartered in Liberty Lake, WA.
Read More

Today's Range

Now: $95.45
Low: $95.10
High: $96.45

50 Day Range

MA: $95.77
Low: $88.32
High: $100.87

52 Week Range

Now: $95.45
Low: $53.49
High: $122.31

Volume

2,541 shs

Average Volume

454,826 shs

Market Capitalization

$4.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

Frequently Asked Questions

What sell-side analysts currently cover shares of Itron?

The following sell-side analysts have issued stock ratings on Itron in the last year: Argus, Canaccord Genuity, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Stephens, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for ITRI.

What is the current price target for Itron?

8 Wall Street analysts have set twelve-month price targets for Itron in the last year. Their average twelve-month price target is $107.13, suggesting a possible upside of 12.5%. Argus has the highest price target set, predicting ITRI will reach $140.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $56.00 for Itron in the next year.
View the latest price targets for ITRI.

What is the current consensus analyst rating for Itron?

Itron currently has 1 sell rating, 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ITRI will outperform the market and that investors should add to their positions of Itron.
View the latest ratings for ITRI.

What other companies compete with Itron?

How do I contact Itron's investor relations team?

Itron's physical mailing address is 2111 N MOLTER ROAD, LIBERTY LAKE WA, 99019. The scientific and technical instruments company's listed phone number is (509) 924-9900 and its investor relations email address is [email protected] The official website for Itron is www.itron.com.